search
California firm
Trends
- 1California firm licenses anti-measles antibodies from Vanderbilt▼California firm licenses ‘potent’ anti-measles antibodies from Vanderbilt Health for development, clinical testing
A California company has licensed potent anti-measles antibodies from Vanderbilt Health to develop them for clinical testing. The agreement moves laboratory research on measles-fighting antibodies toward potential treatments, at a time when measles cases have been resurging in parts of the United States and abroad and health officials are pressing for stronger tools to prevent and treat outbreaks.
- 2California Closes Comment Period on Health Care Deal Reporting Rules●Comment Period Closes on California OHCA’s Proposed Emergency Regulations Expanding Private Equity, Hedge Fund, and MSO Reporting in Health Care Transactions
The comment period has closed on California's Office of Health Care Affordability's proposed emergency regulations, which would expand reporting requirements for health care transactions involving private equity firms, hedge funds, and management services organizations. The rules would require more disclosure of financial backers behind deals in the state's health care market. Stakeholders in health care and investment communities are weighing the impact on deal activity and oversight.
- 3HGGC: Palo Alto Private Equity Firm Focused on Middle-Market Tech▼HGGC: Palo Alto private equity firm investing in middle-market technology and services companies
HGGC is a private equity firm based in Palo Alto, California, that invests in middle-market companies, with a particular focus on technology and services businesses. The firm pursues buyouts and growth investments in mid-sized companies across these sectors, positioning itself as an active investor in the middle-market technology and services space.